Trial of eRapa in Prostate Cancer Patients
Clinical trial NCT03618355 · COMPLETED
Trial details
- NCT number
- NCT03618355
- Sponsor
- Rapamycin Holdings, Inc. dba Emtora Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2019-12-02
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.